Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
Clinical trial NCT03219775 · UNKNOWN
Trial details
- NCT number
- NCT03219775
- Sponsor
- AIO-Studien-gGmbH
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2021-09-16
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.